628-629 / 3107
Cost of toxicity?
Costs
IMRT gynecological cancer
53
Chen Gyn Onc 2015
•
IMRT was associated with reduced late overall toxicity compared to 3DCRT without
compromising clinical outcome.
•
IMRT was not cost-effective during the early chronic toxicity phase, but it became more
cost-effective over time.